Novo’s Ozempic Shortage Is Declared Over, Hitting Copycats
Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...
Investopedia6h
Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply
This comes after the FDA said in October that Eli Lilly weight-loss treatments Mounjaro and Zepbound (which use the active ingredient tirzepatide, rather than semaglutide) were no longer on its list ...
Hims & Hers plunges as the FDA says Novo’s weight loss drugs are not in shortage
Hims & Hers Health (HIMS) stock falls as the FDA declares that Novo Nordisk's (NVO) weight loss therapies are no longer in ...
Novo Nordisk up 6%, Hims & Hers down 15% as FDA says Ozempic shortage over
Shares of Novo Nordisk (NVO) are up 6% in pre-market trading after a FDA drug shortage notice indicated that a shortage of several versions of ...
MarketWatch15h
Copa Holdings S.A. Cl A
Controladora Vuela Compania de Aviacion S.A.B. de C.V. Series A-0.06% $18.32B ...
MarketWatch20h
Nike Inc. Cl B
Under Armour Inc. Cl C-0.89% $2.97B Under Armour Inc. Cl A-1.10% $2.97B ...